1089 related articles for article (PubMed ID: 26581499)
1. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
2. Purinergic mechanisms in neuroinflammation: An update from molecules to behavior.
Beamer E; Gölöncsér F; Horváth G; Bekő K; Otrokocsi L; Koványi B; Sperlágh B
Neuropharmacology; 2016 May; 104():94-104. PubMed ID: 26384652
[TBL] [Abstract][Full Text] [Related]
3. Purinergic contribution to amyotrophic lateral sclerosis.
Volonté C; Apolloni S; Parisi C; Amadio S
Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
[TBL] [Abstract][Full Text] [Related]
4. Adenosine receptors in cerebral ischemia.
Melani A; Pugliese AM; Pedata F
Int Rev Neurobiol; 2014; 119():309-48. PubMed ID: 25175971
[TBL] [Abstract][Full Text] [Related]
5. ATPergic signalling during seizures and epilepsy.
Engel T; Alves M; Sheedy C; Henshall DC
Neuropharmacology; 2016 May; 104():140-53. PubMed ID: 26549853
[TBL] [Abstract][Full Text] [Related]
6. Complementary Role of P2 and Adenosine Receptors in ATP Induced-Anti-Apoptotic Effects Against Hypoxic Injury of HUVECs.
Feliu C; Peyret H; Poitevin G; Cazaubon Y; Oszust F; Nguyen P; Millart H; Djerada Z
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909368
[TBL] [Abstract][Full Text] [Related]
7. Purinergic receptors as potential therapeutic targets in Alzheimer's disease.
Woods LT; Ajit D; Camden JM; Erb L; Weisman GA
Neuropharmacology; 2016 May; 104():169-79. PubMed ID: 26519903
[TBL] [Abstract][Full Text] [Related]
8. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
Abbracchio MP; Cattabeni F
Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415
[TBL] [Abstract][Full Text] [Related]
9. Medicinal chemistry of adenosine, P2Y and P2X receptors.
Jacobson KA; Müller CE
Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
[TBL] [Abstract][Full Text] [Related]
10. Purinergic signaling in kidney disease.
Menzies RI; Tam FW; Unwin RJ; Bailey MA
Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
[TBL] [Abstract][Full Text] [Related]
11. ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors.
Ryu JK; Kim J; Choi SH; Oh YJ; Lee YB; Kim SU; Jin BK
Neuroreport; 2002 Sep; 13(13):1611-5. PubMed ID: 12352612
[TBL] [Abstract][Full Text] [Related]
12. The Selective Antagonism of Adenosine A
Fusco I; Ugolini F; Lana D; Coppi E; Dettori I; Gaviano L; Nosi D; Cherchi F; Pedata F; Giovannini MG; Pugliese AM
Front Pharmacol; 2018; 9():399. PubMed ID: 29740323
[TBL] [Abstract][Full Text] [Related]
13. Purinergic receptors in psychiatric disorders.
Krügel U
Neuropharmacology; 2016 May; 104():212-25. PubMed ID: 26518371
[TBL] [Abstract][Full Text] [Related]
14. Adenosine A2A receptors modulate acute injury and neuroinflammation in brain ischemia.
Pedata F; Pugliese AM; Coppi E; Dettori I; Maraula G; Cellai L; Melani A
Mediators Inflamm; 2014; 2014():805198. PubMed ID: 25165414
[TBL] [Abstract][Full Text] [Related]
15. Agonists and Antagonists for Purinergic Receptors.
Müller CE; Baqi Y; Namasivayam V
Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
[TBL] [Abstract][Full Text] [Related]
16. CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17.
Fumagalli M; Lecca D; Abbracchio MP
Neuropharmacology; 2016 May; 104():82-93. PubMed ID: 26453964
[TBL] [Abstract][Full Text] [Related]
17. Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets.
Jacobson KA; IJzerman AP; Müller CE
Biochem Pharmacol; 2021 May; 187():114311. PubMed ID: 33130128
[TBL] [Abstract][Full Text] [Related]
18. Purinergic receptors in embryonic and adult neurogenesis.
Oliveira Á; Illes P; Ulrich H
Neuropharmacology; 2016 May; 104():272-81. PubMed ID: 26456352
[TBL] [Abstract][Full Text] [Related]
19. P2X7 receptors mediate ischemic damage to oligodendrocytes.
Domercq M; Perez-Samartin A; Aparicio D; Alberdi E; Pampliega O; Matute C
Glia; 2010 Apr; 58(6):730-40. PubMed ID: 20029962
[TBL] [Abstract][Full Text] [Related]
20. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
Washburn KB; Neary JT
Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
